Adjust Text Size:change font sizechange font sizechange font sizechange font sizechange font sizechange font size

WPC 2016


PDF at the WPC: Master Schedule

This week, from Tuesday, September 20 until Friday, September 23, we are bringing team of more than 100 staff, patient advocates and PDF-supported researchers and health professionals to the 4th World Parkinson Congress (WPC).

How can you find us? See our schedule below and come find us at WPC.

Tuesday, September 20

[+] PDF Staff and Patient Leaders

Pre-congress Panel: So you want new treatments? How are you helping bring new treatments to pharmacy? Or are you waiting for someone else to do the work? (Veronica Todaro, M.P.H., Vice President, National Programs, PDF; Pat Davies, PDF Research Advocate; Israel Robledo, PDF Research Advocate)
Oregon Ballroom 201-202 1:30 PM to 3:15 PM PT

Pre-congress Panel: Changing how care is delivered: A success the PD community can take pride in (James Beck, Ph.D., Vice President, Scientific Affairs, PDF)
Oregon Ballroom 204, 2:00 PM to 3:00 PM PT

Pre-congress Course: Introduction: The patient experience (Rebecca Miller, Ph.D., Member, PDF People with Parkinson’s Advisory Council)
Oregon Ballroom 204, 3:45 PM to 5:45 PM PT

Opening Ceremony (Meet the PDF team at booth #406)
Exhibit Hall C, 6:30 PM to 7:45 PM PT)

 

[+] Research Leaders

Pre-congress Course I: Clinical features of Parkinson’s disease (Anthony Lang, M.D.)
Oregon Ballroom 201-202, 9:00 AM to 10:10 AM PT

Pre-congress Course I, Co-moderator: So you want new treatments? How are you helping bring new treatments to the pharmacy? Or are you waiting for someone else to do the work? (Michael Schwarzschild, M.D., Ph.D.)
Oregon Ballroom 201-202, 1:20 PM to 2:30 PM PT

Pre-congress Course III: Dyskinesia, Talk #2: Clinical forms of dyskinesia (Un Jung Kang, M.D.)
Oregon Ballroom 204, 12:30 PM to 1:45 PM PT

Pre-congress Course III: Perspectives on psychosis in PD, Talk #3: History of psychosis and hallucination in PD- A look at the writings of Oliver Sacks (Stanley Fahn, M.D.)
Oregon Ballroom 204, 3:45 PM to 5:45 PM PT

 

[+] Nurse Leaders

Pre-congress Course I: How to pick a good health care team and why it’s so important to ask the right questions (Julie Carter, R.N., M.S., A.N.P.)
Oregon Ballroom 201-202 2:55 PM to 4:20 PM PT

 


Wednesday, September 21

[+] PDF Staff and Patient Leaders

Roundtable #7: Shame and PD: How to recognize it and help fellow PwPs conquer it (Julio Angulo, Ph.D., Member, PDF People with Parkinson’s Advisory Council)
Room A105-106, 1:30 to 3:00 PM PT

Parallel Session: Pathology and Mechanisms of Cognitive Deficits in PD (Rebecca Miller, Ph.D., Member, PDF People with Parkinson’s Advisory Council and Jennifer G. Goldman, M.D., M.S.; clinician and researcher, PDF Research Center at Rush University Medical Center)
Room B113-114, 1:30 to 3:00 PM PT

Voces del Parkinson: Soy el compás de otra canción sung by the Spanish speaking WPC community (Alejandra Borunda, PDF Advocate)
WPC Music Spot, 3:00 PM PT

 

[+] Research Leaders

James Parkinson’s Special Lecture Introduction Speaker: Levodopa over the last 50 years, where we've come and where we are going (Stanley Fahn, M.D.)
Exhibit Hall C, 12:00 PM to 1:15 PM PT

Parallel Session, Co-chair: Pathology and mechanisms of cognitive deficits in PD (Jennifer Goldman, M.D., M.S.)
Room B113-114, 1:30 PM to 3:00 PM PT

Parallel Session, Co-chair: Transcription factors and survival of da neurons (Jeffrey Kordower, Ph.D.)
Room B110-112, 3:30 PM to 5:00 PM PT

Parallel Session Speaker, Lecture #1: Mechanisms of impulse control disorders in PD (T. Celeste Napier, Ph.D.)
Room B113-114, 3:30 PM to 5:00 PM PT

Parallel Session Speaker, Lecture #2: Imaging of impulse control disorders in PD: What have we learned (Antonio Strafella, M.D., Ph.D.)
Room B113-114, 3:30 PM to 5:00 PM PT

Parallel Session Speaker, Lecture #2: Targeting TNF-dependent inflammation and neurotoxicity in neurodegenerative diseases (Malu Tansey, Ph.D.)
Oregon Ballroom 201, 3:30 PM to 5:00 PM PT

Workshop Co-moderator: Gut Microbiome and Parkinson's (Jeffrey Kordower, Ph.D., and Michael Schwarzschild, M.D., Ph.D.)
Room B115-116. 1:30 PM to 3:00 PM PT

Workshop Co-moderator: Depression and anxiety – update on assessment and management of key non-motor features (Antonio Strafella, M.D., Ph.D.)
Oregon Ballroom 203. 1:30 PM to 3:00 PM PT

Workshop Panelist, Talk #3: Non-pharmacological management of depression (Roseanne Dobkin, Ph.D.)
Oregon Ballroom 203, 1:30 PM to 3:00 PM PT

Roundtable #2: Cannabis and Parkinson’s: What’s all the fuss? (Benzi Kluger, M.D., M.S.)
Room A105-106, 1:30 PM to 3:00 PM PT

End-of-day wrap-up Panelist (Stanley Fahn, M.D.)
Exhibit Hall C, 5:15 PM to 6:15 PM PT

 

[+] Nurse Leaders

Roundtable #1: Tools for living with young-onset PD (Ruth Hagestuen, R.N., M.A.)
Room A105-106, 3:30 PM to 5:00 PM PT

Roundtable #6: PD and children: How does PD impact children? (Amy Lemen, M.A., L.C.S.W.)
Room A105-106, 3:30 PM to 5:00 PM PT

 


Thursday, September 22

[+] PDF Staff and Patient Leaders

Abstract #885: Outcomes of the PDF Community Choice Research Award: a workshop to address maintaining cognitive function in Parkinson’s (Beth Vernaleo, Ph.D., Associate Director of Research Programs, PDF; Jennifer G. Goldman, M.D., M.S.; clinician and researcher, PDF Research Center at Rush University Medical Center)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P26.17
Download this poster here.

Abstract #1243: Engaging people with Parkinson’s in determining and defining research priorities: The PDF Community Choice Research Award (Karlin Schroeder, M.A., Associate Director, National Programs, PDF; Beth Vernaleo, Ph.D., Associate Director, Research Programs, PDF; Diane Cook, PDF Research Advocate; James Beck, Ph.D., Vice President, Scientific Affairs, PDF; Veronica Todaro, M.P.H., Vice President, National Programs, PDF)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P23.25)
Download this poster here.

Abstract P23.18: What PD symptoms should be monitored and which most impact quality of life? (PDF Research Advocate, Steve DeWitte)
Exhibit Hall 11:30 AM to 1:30 PM PT, P23.18

Book Discussion: Introducing Day I Found Out Why (Israel Robledo, PDF Research Advocate)
Exhibit Hall: 11:30 AM to 1:30 PM, Booth #925

Clinical Research Village Meet the Villagers! The PD Trial Coordinators, doctors and practitioners who will explain their roles and answer your questions and learn how you can contribute to progress (Veronica Todaro, M.P.H., Vice President, National Programs, PDF)
Exhibit Hall, 12:00 PM to 1:15 PM PT

Workshop: Palliative care and PD: a patient perspective (Kirk Hall, M.B.A., PDF Research Advocate)
Oregon Ballroom 204, 1:30 PM to 3:00 PM PT

Roundtable #6: PD & children: How does PD impact children? (Rebecca Miller, Ph.D., member PDF People with Parkinson’s Advisory Council)
Room A105-106, 3:30 PM to 5:00 PM PT

Book Discussion: Parkinson’s Treatment: 10 Secrets to a Happier Life (Michael Okun, M.D., National Medical Director, Parkinson’s Foundation)
Exhibit Hall, 5:30 PM PT

 

[+] Research Leaders

Hot Topics, Abstract 26.13: Large-scale exploratory analysis of genetic risk factors for cognitive impairment in Parkinson’s disease (Ignacio Mata, Ph.D.)
Exhibit Hall C, 8:00 AM to 9:00 AM PT, P26.13

Hot Topics Moderator (Serge Przedborski, M.D., Ph.D.)
Exhibit Hall C, 8:00 AM to 9:00 AM PT

Morning Plenary, Co-chair: Genes and mechanisms of sporadic PD (Caroline Tanner, M.D., Ph.D.)
Exhibit Hall C, 9:15 AM to 11:15 AM PT

Parallel Session, Co-Chair: Cell-to-cell transmission of alpha-synuclein (Serge Przedborski, M.D., Ph.D.)
Oregon Ballroom 201, 1:30 PM to 3:00 PM PT

Parallel Session, Co-Chair: Novel therapeutic approaches for dyskinesia (Un Jung Kang, M.D.)
Oregon Ballroom 201, 3:30 PM to 5:00 PM PT

Parallel Session Speaker, Lecture #3: Sleep and cognition in PD (Jennifer Goldman, M.D., M.S.)
Oregon Ballroom 203, 1:30 PM to 3:00 PM PT

Parallel Session Speaker, Lecture #3: Neuroinflammation in Parkinson’s disease: A risk factor and a therapeutic opportunity (Malu Tansey, Ph.D.)
Room B113-114, 1:30 PM to 3:00 PM PT

Workshop Panelist, Talk #1: What is palliative care and why is it relevant to PD? (Benzi Kluger, M.D., M.S.)
Oregon Ballroom 204, 1:30 PM to 3:00 PM PT

Workshop Panelist, Talk #1: The role of autophagy in PD (Sheng-Han Kuo, M.D.)
Room B110-112, 1:30 PM to 3:00 PM PT

Workshop Panelist, Talk #1: PINK1/ Parkin-mediated mechanisms (Leo Pallanck, Ph.D.)
Room B115-116, 1:30 PM to 3:00 PM PT

Workshop Panelist, Talk #2: Clinical features, diagnosis and treatment of MCI (Jennifer Goldman, M.D., M.S.)
Oregon Ballroom 204, 3:30 PM to 5:00 PM PT

Workshop Panelist, Talk #3: Linking changes in gut microbiome to alpha-synuclein misfolding as an early trigger of the disease process in Parkinson’s (Kathleen Shannon, M.D.)
Room B115-116, 1:30 PM to 3:00 PM PT

Late Breaking, P3: Melanoma-linked MC1R supports dopaminergic neuron survival (Michael Schwarzschild, M.D., Ph.D.)
Exhibit Hall, 11:30 AM to 1:30 PM PT

Abstract 01.02: First report of LRRK2-G2019S mutation in Parkinson’s disease patients from Ecuador (Ignacio Mata, Ph.D.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P01.02

Abstract 01.04: Prevalence of Parkinson’s disease in North America: a nationwide epidemiological study sharing available databases (James Beck, Ph.D., Vice President, Scientific Affairs, PDF; Roy Alcalay, M.D., M.S., scientist and clinician at the PDF Research Center at Columbia University Medical Center; James Bower, M.D.; Hongle Chen, M.D., Ph.D.; Connie Marras, M.D., Ph.D.; Brad Racette, M.D.; Beate Ritz, M.D., Ph.D.; G. Webster Ross, M.D.; Rodolfo Savica, M.D., Ph.D.; Michael Schwarzschild, M.D., Ph.D.; Caroline Tanner, M.D., Ph.D.; Stephen Van Den Eeden, Ph.D.; Allison Willis, M.D., M.S., and Bill Wilson, PDF Research Advocate)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P01.04
Download this poster here.

Abstract 01.08: Polychlorinated biphenyls (PCBs) are associated with Parkinson’s disease risk in two populations (Caroline Tanner, M.D., Ph.D.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P01.08

Abstract 01.12: Variable frequency of LRRK2 mutations in Latin America, a case of ancestry (Ignacio Mata, Ph.D.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P01.12

Abstract 01.15: Association of brain organochlorines with Lewy pathology (Caroline Tanner, M.D., Ph.D.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P01.15

Abstract 01.16: Nonsteroidal anti-inflammatory drugs (NSAIDs) and penetrance of LRRK2 Parkinson’s disease (Anthony Lang, M.D., and Caroline Tanner, M.D., Ph.D.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P01.16

Abstract 02.01: Marinesco bodies and substantia nigra neuron density in Parkinson’s disease (Caroline Tanner, M.D., Ph.D.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P02.01

Abstract 02.06: Accumulation of PARIS (ZNF746) plays a role in α-synuclein-induced neurodegeneration (Preston Ge)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P02.06

Abstract 04.07: Do PINK1 and Parkin influence the accumulation of mitochondrial DNA mutations in somatic tissues? (Leo Pallanck, Ph.D.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P04.07

Abstract 25.02: Addicted to technology: Parkinson’s disease and impulse control in the age of technology (Caroline Tanner, M.D., Ph.D.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P25.02

Abstract 26.05: Trajectories of cognitive impairment in Parkinson’s disease (PD-TCI) (Jennifer Goldman, M.D., M.S.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P26.05

Abstract 26.17: Outcomes of the PDF Community Choice Research Award: a workshop to address maintaining cognitive function in Parkinson’s (Jennifer Goldman, M.D., M.S.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P26.17

Abstract 26.18: SYN120, a dual 5-HT6/5-HT2A antagonist, for Parkinson’s disease dementia (PDD) (SYNAPSE study): study design and partial blinded baseline data (Michael Schwarzschild, M.D., Ph.D.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P26.18

Abstract 27.05: Differences between actual and perceived treatment groups in a double-blind placebo trial of acupuncture for fatigue in Parkinson’s disease (Benzi Kluger, M.D., M.S.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P27.05

Abstract 29.01: Injury rates for people with Parkinson's are predicted by Parkinson’s severity independent of demographic data (Caroline Tanner, M.D., Ph.D.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P29.01

Abstract 30.08: Diurnal fluctuations of inflammatory factors in CSF and serum and identification of inflammatory markers that can be used to discriminate between Parkinson’s disease and age-matched healthy controls (Malu Tansey, Ph.D.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P30.08

Abstract 30.12: Cerebellar volumes and cognitive differences between Parkinson’s disease with and without freezing of gait (Gammon Earhart, P.T., Ph.D.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P30.12

Abstract 31.22: Efficacy of IPX066, extended-release carbidopa-levodopa, in advanced Parkinson’s disease patients with limited levodopa treatment duration (Leo Verhagen-Metman, M.D., Ph.D.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P31.22

 

[+] Nurse Leaders

WPC Award for Distinguished Contribution to the Parkinson Community (Julie Carter, R.N., M.S., A.N.P.)
Exhibit Hall C, 9:00 AM to 9:15 AM

Care Partner Lounge, Small Group Discussion: Cognitive challenges: How to recognize them and get the help you need (Amy Lemen, M.A., L.C.S.W.)
Wellness Way, 3:30 PM to 5:00 PM PT

Abstract 12.06: Enhanced wellness for the Parkinson’s care partner through group support (Amy Lemen, M.A., L.C.S.W.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P12.06

Abstract 14.13: Development and testing of a yoga intervention program for subjects with Parkinson’s disease (Corjena Cheung, Ph.D., R.N.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P14.13

Abstract 14.18: Complementary and alternative medicine (CAM) use in people with Parkinson’s disease (PD) (Ju Young Shin, Ph.D., A.P.N., A.N.P-C.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P14.18

Abstract 22.02: Redefining social work for Parkinson’s: the development of a new model of care for specialized, comprehensive support in the clinic, community and home (Amy Lemen, M.A., L.C.S.W.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P22.02

Abstract 22.03: Medication errors: the role of the nurse in an interdisciplinary home visit program for advanced Parkinson’s disease patients (Sarah Oyler, R.N., and Amy Lemen, M.A., L.C.S.W.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P22.03

Abstract 22.04: Assessment and connection to care: the vital role of the social worker in an interdisciplinary home visit program for advanced Parkinson’s disease patients (Sarah Oyler, R.N. and Amy Lemen, M.A., L.C.S.W.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P22.04

Abstract 23.01: A targeted web-based approach to support staff nurse learning in the care of Parkinson’s disease patients in acute care settings (Michael Clark, D.N.P., G.N.P., R.N.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P23.01

Abstract 23.02: Silver Snowflake Parkinson Fall Prevention Initiative: overview (Klaudia Lewis, M.S.N., R.N., A.P.H.N.-B.C.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P23.02

Abstract 23.12: Constipation and Parkinson’s disease (Jean MacFadyen, Ph.D., R.N., and Gwyn Vernon, M.S.N., R.N., C.R.N.P.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P23.12

Abstract 23.27: Motor and non-motor symptoms of Parkinson’s disease by gender and disease duration (Ju Young Shin, Ph.D., A.P.N., A.N.P-C.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P23.27

Abstract 27.02: The association of fatigue and sleep problems with retention of daily life activities in people with Parkinson’s disease (Cathi Thomas, R.N., M.S., C.N.R.N.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P27.02

Abstract 31.14: A successful quality improvement process for improving timely levodopa administration in the hospital (Joan Gardner, R.N., B.S.N.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P31.14

Abstract 32.17: Rechargeable deep brain stimulator (DBS) batteries: exploring possible predictors of patient satisfaction and experience (Monica Volz, R.N., M.S.N.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P32.17

Abstract 38.07: A Learning community for nursing faculty: dissemination and the discovery of caring for people living with Parkinson’s disease (Margaret McCormick, M.S., R.N.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P38.07

Abstract 38.08: Improving nursing education on Parkinson’s disease (Diane Ellis, M.S.N., R.N., and Gwyn Vernon, M.S.N., R.N., C.R.N.P.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P38.08

Abstract 42.03: An interdisciplinary Parkinson’s disease case study event for dietetics, education, exercise science, health care administration, nursing and social work students: enhancing effective communication between disciplines (Jennifer Bailey Dejong, Ph.D., F.N.P-B.C., C.N.E., R.N.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P42.03

 


Friday, September 23

[+] PDF Staff and Patient Leaders

Abstract #1236: The PDF Women and PD Initiative: identifying and addressing unmet needs (Megan Feeney, M.P.H., National Programs Manager, PDF; Veronica Todaro, M.P.H., Vice President, National Programs, PDF; Lori Katz, PDF Advocate Susan Foster, PDF Advocate, Robin Morgan, PDF Advocate; and Karen Smith, PDF Advocate)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P19.13
Download this poster here.

Abstract P19.07: Art as a vehicle to represent the Spanish speaking Parkinson’s community in the Americas (Julio Angulo, Ph.D., Member, PDF People with Parkinson’s Advisory Council)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P19.07

Abstract P21.01: Hispanics living with PD: perceptions on self-management (Julio Angulo, Ph.D., Member, PDF People with Parkinson’s Advisory Council)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P21.01

Abstract P21.04: Long-term effects of self-efficacy enhancing program for newly-diagnosed persons with Parkinson’s disease (Diane Cook, PDF Research Advocate)
Exhibit Hall, 11:30 AM to 1:30 PM, P21.05

Abstract #1241: Parkinson’s Advocates in Research: A Parkinson’s Disease Foundation cutting edge program in patient engagement in research (Karlin Schroeder, M.A., Associate Director, National Programs, PDF; Veronica Todaro, M.P.H., Vice President, National Programs, PDF; Linda Morgan, PDF Research Advocate; and Cliff Ishmael, PDF Research Advocate)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P35.23
Download this poster here.

Abstract #1231: Driving patient engagement in Parkinson’s clinical research: lessons learned in developing successful partnerships with study sponsors (Karlin Schroeder, M.A., Associate Director, National Programs, PDF; Veronica Todaro, M.P.H., Vice President, National Programs, PDF)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P35.22
Download this poster here.

Abstract #1152: Does gender influence the types of questions asked by people living with Parkinson’s? (Christiana Evers, M.P.A., Vice President, Communications, PDF; Linda Pituch, Senior Patient Services Manager, PDF; Jill McClure, Patient Services Manager, PDF; Jeanne Kirby, Information Specialist, PDF; Casey Gallagher, Administrative Assistant, PDF; and Nancy Ralph)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P21.07
Download this poster here.

Abstract P40.26: Living well by doing [*]; keeping it interesting (Daniel Novak, Ph.D., Chair, PDF People with Parkinson’s Advisory Council)
Exhibit Hall, 11:30 AM to 1:30 PM PT P40.26

Roundtable #6; Palliative care treatment options: What works best from the health professional and patient perspectives (Kirk Hall, M.B.A., PDF Research Advocate)
Room A105-106, 1:30 PM to 3:00 PM PT

Workshop: Challenges for industry in advancing new PD therapies and how collaborative networks like CPP help (Kevin Kwok, PDF Research Advocate)
Room B115-116, 1:30 PM to 3:00 PM PT

 

[+] Research Leaders

WPC Award Ceremony (Host) Serge Przedborski, M.D., Ph.D.)
Exhibit Hall C, 9:00 AM to 9:15 AM PT

Parallel Session, Co-chair: Mechanisms of Dyskinesia: New Insights from Animal Models (T. Celeste Napier, Ph.D.)
Oregon Ballroom 201, 1:30 PM to 3:00 PM PT

Parallel Session Speaker, Lecture #1: Serotonergic mechanisms of dyskinesia (Manolo Carta, Ph.D.)
Oregon Ballroom 201, 1:30 PM to 3:00 PM PT

Parallel Session Speaker, Lecture #2: Gastrointestinal dysfunction (Kathleen Shannon, M.D.)
Oregon Ballroom 202, 1:30 PM to 3:00 PM PT

Parallel Session Speaker, Lecture #3: Practical implications: Integration of exercise into everyday life (Gammon Earhart, P.T., Ph.D.)
Exhibit Hall C, 1:30 PM to 3:00 PM PT

Parallel Session Speaker, Lecture #3: Cholinergic cells in dyskinesia: Experimental evidence and novel treatments (Un Jung Kang, M.D.)
Oregon Ballroom 201, 3:30 PM to 5:00 PM PT

Workshop Co-moderator: Emerging Mitochondrial Concepts in PD (Leo Pallanck, Ph.D.)
Room B113-114, 3:30 PM to 5:00 PM PT

Workshop Panelist, Talk #1: In vivo cell specific striatal manipulations and behavior (Alexandra Nelson, M.D., Ph.D.)
Room B110-112, 1:30 PM to 3:00 PM PT

Workshop Panelist, Talk #1: Research on cannabis: Is there any evidence? (Benzi Kluger, M.D., M.S.)
Oregon Ballroom 204, 3:30 PM to 5:00 PM PT

Roundtable #6, Host: Chemical exposure and neurodegenerative disease (Caroline Tanner, M.D., Ph.D.)
Room A105-106, 3:30 PM to 5:00 PM PT

Roundtable #7, Co-host: Environmental toxins and PD: What do we know today? (Caroline Tanner, M.D., Ph.D.)
Room A105-106, 1:30 PM to 3:00 PM PT

End-of-day wrap-up Panelist (Alexandra Nelson, M.D., Ph.D.)
Exhibit Hall C, 5:15 PM to 6:15 PM PT

Abstract 06.14: Targeting soluble TNF with XPro1595 to ameliorate motor and non-motor symptoms in a progressive non-human primate model of Parkinson’s disease (Malu Tansey, Ph.D.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P06.14

Abstract 06.15: The role of myeloid MHC-II in α-synuclein-induced degeneration and risk for PD (Malu Tansey, Ph.D.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P06.15

Abstract 19.05: Preliminary results of a multi-center case series of virtual visits for Parkinson’s disease (Caroline Tanner, M.D., Ph.D.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P19.05

Abstract 19.11: Nurse-managed telehealth clinic for Parkinson’s disease: a case series (Roseanne Dobkin, Ph.D.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P19.11

Abstract 33.20: Characterizing maximum step length test performance in people with Parkinson’s disease (Gammon Earhart, P.T., Ph.D.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P33.20

Abstract 33.31: Singing as a cue to improve gait in Parkinson’s disease: a feasibility study (Gammon Earhart, P.T., Ph.D.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P33.31

Abstract 33.45: Quantity and intensity of physical activity in people with Parkinson’s disease during exercise interventions (Gammon Earhart, P.T., Ph.D.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P33.45

Abstract 33.47: Three-dimensional evaluation of postural stability in Parkinson’s disease with mobile technology (Sarah Ozinga, B.Sc.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P33.47

Abstract 35.09: Does outpatient palliative care improve patient centered outcomes in Parkinson’s disease: study protocol for a multi-center randomized controlled trial (Benzi Kluger, M.D., M.S.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P35.09

Abstract 35.15: ADS-5102 (amantadine HCl) extended-release capsules improves activities of daily living (ADLs) in Parkinson’s disease (PD)patients by reducing levodopa-induced dyskinesia (LID): a post-hoc analysis from the phase 3 EASE LID study (Caroline Tanner, M.D., Ph.D.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P35.15

Abstract 35.20: Results of a phase 3 efficacy and safety study of ADS-5102 (amantadine HCl) extended-release capsules in Parkinson’s disease patients with levodopa-induced dyskinesia (Caroline Tanner, M.D., Ph.D.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P35.20

 

[+] Nurse Leaders

Roundtable #6: Palliative care treatment options: What works best from the health professional and patient perspectives (Julie Carter, R.N., M.S., A.N.P.)
Room A105-106, 1:30 PM to 3:00 PM PT

Abstract 15.01: Enhancing care for the hospitalized patient with Parkinson’s disease: development of a formal educational program for nursing staff (Mary DiBartolo, Ph.D., M.B.A., R.N.-B.C.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P15.01

Abstract 15.03: Conversation mapping as a technique to train student nurses in the care of Parkinson’s disease patients and family members (Marjorie Getz, Ph.D.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P15.03

Abstract 15.06: Meet Val and Holly: An experiential tour through the lives of a PD family (Laura Kelly, Ph.D., A.P.N., C.N.S., and Cheryl Leiningen, D.N.P., R.N., A.P.N-C.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P15.06

Abstract 18.02: Feasibility and preliminary outcomes of an interdisciplinary home visit program for patients with advanced Parkinson’s disease (Sarah Oyler, R.N., and Amy Lemen, M.A., L.C.S.W.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P18.02

Abstract 19.11: Nurse-managed telehealth clinic for Parkinson’s disease: a case series (Jenny Hughes, M.S.N., R.N., F.N.P., Ingrid Pretzer-Aboff, Ph.D., M.A., R.N., and Susan Cross-Skinner, A.N.P.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P19.11

Abstract 19.12: Telemedicine clinic improves access to mental health care for people with Parkinson’s disease (Ingrid Pretzer-Aboff, Ph.D., M.A., R.N.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P19.12

Abstract 19.14: Struthers Parkinson’s Center Network (SPCN): improving PD care through growth and development of sustainable partnerships (Joan Gardner, R.N., B.S.N., and Ruth Hagestuen, R.N., M.A.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P19.14

Abstract 21.02: Parkinson’s Disease: support groups use of PhotoVoice to share experiences (Joyce Bredesen, D.N.P., R.N.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P21.02

Abstract 21.06: Nursing advocacy in assessment of the Parkinson’s patient in acute and outpatient urgent care: impact on health and quality of life (Mary Lou De Natale, Ed.N., R.N., C.N.L.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P21.06

Abstract 21.14: Baseline characteristics of a longitudinal study of the social self-management of Parkinson’s disease (SocM-PD) (Cathi Thomas, R.N., M.S., C.N.R.N.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P21.14

Abstract 33.36: The LSVT BIG intervention in clients with Parkinson’s disease: a systematic review (Mary DiBartolo, Ph.D., M.B.A., R.N.-B.C.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P33.36

Abstract 33.70: Medication management in women and men with Parkinson’s disease: challenges and strategies (Cathi Thomas, R.N., M.S., C.N.R.N.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P33.70

Abstract 37.10: Innovative use of mobile health technology in physical therapy for people with Parkinson’s disease (Cathi Thomas, R.N., M.S., C.N.R.N.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P37.10

Abstract 38.07: The role of the advanced practice nurse in the management of Parkinson’s disease (Kathleen McCoy, D.N.Sc., A.P.R.N., R.N.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P38.07

Abstract 40.18: From local partnership to national network: the growth of a medically connected, community based Parkinson’s wellness program model (Ruth Hagestuen, R.N., M.A., and Amy Lemen, M.A., L.C.S.W.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P40.18

Abstract 40.31: From patient to athlete: the development of a novel goal based, interdisciplinary group exercise model for Parkinson’s disease (Amy Lemen, M.A., L.C.S.W.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P40.31

Abstract 40.36: Hospitalized patients with Parkinson’s disease: using the electronic medical record to reduce medication errors and reinforce staff education at St. Joseph’s Hospital and Medical Center and Barrow Neurological Institute (Edie Simpson, R.N.)
Exhibit Hall, 11:30 AM to 1:30 PM PT, P40.36

 

Back to Top of Page